Bariatric surgery and renal function: A precarious balance between benefit and harm

Nephrology Dialysis Transplantation

Volumn 25, Issue 10, 2010, Pages 3142-3147

  Ahmed, Mohamed H ^a   Byrne, Christopher D ^b  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

bariatric surgery; obesity; oxalate nephropathy; renal stone

Indexed keywords

ADIPONECTIN; ALBUMIN; C REACTIVE PROTEIN; INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; OXALIC ACID; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ACIDURIA; ACUTE CORONARY SYNDROME; ADIPOSE TISSUE; ALBUMINURIA; ATHEROSCLEROSIS; BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; BODY MASS; DIABETIC NEPHROPATHY; DYSLIPIDEMIA; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; GLUCOSE TOLERANCE; HEMODIALYSIS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LAPAROSCOPIC SURGERY; LIFESTYLE MODIFICATION; MEMBRANOUS GLOMERULONEPHRITIS; MORBIDITY; MORTALITY; NEPHROLITHIASIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; STOMACH BYPASS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADIPONECTIN; BARIATRIC SURGERY; CALCIUM OXALATE; HUMANS; HYPEROXALURIA; INTERLEUKIN-18; KIDNEY; KIDNEY CALCULI; OBESITY, MORBID;

EID: 77957223077     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq347     Document Type: Review

References (57)

1. Blair SN, Brodney S. Effects of physical inactivity and obesity on morbidity and mortality: current evidence and research issues. Med Sci Sports Exerc 1999; 31: S646-S662
2. Navaneethan SD, Yehnert H, Moustarah F et al. Weight loss interventions in chronic kidney disease: a systematic review and meta-ana-lysis. Clin J Am Soc Nephrol 2009; 4: 1565-1574
3. Ahmed MH, Byrne CD. Metabolic syndrome, diabetes & CHD risk. In: CJ Packard (ed). The Year in Lipid Disorders. Oxford: Clinical Publishing, 2007; 3-26
4. Ahmed MH, Khalil A, Osman MM. Nitric oxide as treatment for an emerging epidemic of obesity-related glomerulopathy. Diab Res Clin Pract 2006; 74: 207-208
5. Hall JE, Jones DW, Kuo JJ et al. Impact of the obesity epidemic on hypertension and renal disease. Curr Hypertens Rep 2003; 5: 386-392
6. Wesson DE, Kurtzman NA, Frommer JP. Massive obesity and neph-rotic proteinuria with a normal renal biopsy. Nephron 1985; 40: 235-237
7. Kambham N, Markowitz GS, Valeri AM et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001; 59: 1498-1509
8. Brenner BM, Garcia DL, Anderson S. Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens 1988; 1: 335-347
9. Hales CN, Barker DJ. The thrifty phenotype hypothesis. Br Med Bull 2001; 60: 5-20
10. Baum M. Role of the kidney in the prenatal and early postnatal programming of hypertension. Am J Physiol Ren Physiol 2010; 298: F235-F247
11. Li S, Chen SC, Shlipak M et al. Low birth weight is associated with chronic kidney disease only in men. Kidney Int 2008; 73: 637-642
12. Luyckx VA, Compston CA, Simmen T et al. Accelerated senescence in kidneys of low-birth-weight rats after catch-up growth. Am J Physiol Ren Physiol 2009; 297: F1697-F1705
13. Bagby SP. Maternal nutrition, low nephron number, and hypertension in later life: pathways of nutritional programming. J Nutr 2007; 137: 1066-1072
14. Barker DJ, Bagby SP, Hanson MA. Mechanisms of disease: in utero programming in the pathogenesis of hypertension. Nat Clin Pract Nephrol 2006; 2: 700-707
15. Obligado SH, Goldfarb DS. The association of nephrolithiasis with hypertension and obesity:a review. Am JHypertens 2008; 21: 257-264
16. Negri AL, Spivacow FR, Del Valle EE et al. Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers. Urol Res 2008; 36: 303-307
17. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA 2005; 293: 455-462
18. Semins MJ, Shore AD, Makary MA et al. The association of increasing body mass index and kidney stone disease. J Urol 2009
19. Lee SC, Kim YJ, Kim TH et al. Impact of obesity in patients with urolithiasis and its prognostic usefulness in stone recurrence. J Urol 2008; 179: 570-574
20. Asplin JR. Obesity and urolithiasis. Adv Chron Kidney Dis 2009; 16: 11-20
21. Cignarelli M, Lamacchia O. Obesity and kidney disease. Nutr Metab Cardiovasc Dis 2007; 17: 757-762
22. Brethauer SA, Chand B, Schauer PR. Risks and benefits of bariatric surgery: current evidence. Cleve Clin J Med 2006; 73: 993-1007
23. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 2001; 60: 329-339
24. Okamura H, Tsutsui H, Kashiwamura S et al. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv Immunol 1998; 70: 281-312
25. Mallat Z, Henry P, Fressonnet R et al. Increased plasma concentrations of interleukin-18 in acute coronary syndromes. Heart 2002; 88: 467-469
26. Mallat Z, Corbaz A, Scoazec A et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001; 104: 1598-1603
27. Blankenberg S, Tiret L, Bickel C et al. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 2002; 106: 24-30
28. Cnop M, Havel PJ, Utzschneider KM et al. Relationship of adiponec-tin to body fat distribution, insulin sensitivity and plasma lipopro-teins: evidence for independent roles of age and sex. Diabetologia 2003; 46: 459-469
29. Hivert MF, Sullivan LM, Fox CS et al. Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. J Clin Endocrinol Metab 2008; 93: 3165-3172
30. Vilarrasa N, Vendrell J, Sanchez-Santos R et al. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adipo-nectin in morbidly obese patients. Clin Endocrinol (Oxf) 2007; 67: 679-686
31. Holdstock C, Lind L, Engstrom BE et al. CRP reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects. Int J Obes (Lond) 2005; 29: 1275-1280
32. Whitson BA, Leslie DB, Kellogg TA et al. Adipokine response in diabetics and nondiabetics following the Roux-en-Y gastric bypass: a preliminary study. J Surg Res 2007; 142: 295-300
33. Shah SS, Todkar JS, Shah PS et al. Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index
34. Adams TD, Gress RE, Smith SC et al. Long-term mortality after gastric bypass surgery. N Engl J Med 2007; 357: 753-761
35. Sjostrom L, Narbro K, Sjostrom CD et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741-752
36. Navaneethan SD, Kelly KR, Sabbagh F et al. Urinary albumin excretion, HMWadiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery. Obes Surg 2009
37. Batsis JA, Lopez-Jimenez F, Collazo-Clavell ML et al. Quality of life after bariatric surgery: a population-based cohort study. Am J Med 2009; 122: 1055
38. Habib P, Scrocco JD, Terek M et al. Effects of bariatric surgery on inflammatory, functional and structural markers of coronary atherosclerosis. Am J Cardiol 2009; 104: 1251-1255
39. Navaneethan SD, Yehnert H. Bariatric surgery and progression of chronic kidney disease. Surg Obes Relat Dis 2009; 5: 662-665
40. Huan Y, Tomaszewski JE, Cohen DL. Resolution of nephrotic syndrome after successful bariatric surgery in patient with biopsy-proven FSGS. Clin Nephrol 2009; 71: 69-73
41. Szomstein S, Rojas R, Rosenthal RJ. Outcomes of laparoscopic bar-iatric surgery after renal transplant. Obes Surg 2009
42. Navarro-Diaz M, Serra A, Romero R et al. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. J Am Soc Nephrol 2006; 17: S213-S217
43. Alexander JW, Goodman HR, Hawver LR et al. Improvement and stabilization of chronic kidney disease after gastric bypass. Surg Obes Relat Dis 2009; 5: 237-241
44. Agrawal V, Khan I, Rai B et al. The effect of weight loss after bar-iatric surgery on albuminuria. Clin Nephrol 2008; 70: 194-202
45. Saliba J, Kasim NR, Tamboli RA et al. Roux-en-Y gastric bypass reverses renal glomerular but not tubular abnormalities in excessively obese diabetics. Surgery 2010; 147: 282-287
46. Matlaga BR, Shore AD, Magnuson T et al. Effect of gastric bypass surgery on kidney stone disease. J Urol 2009; 181: 2573-2577
47. Semins MJ, Matlaga BR, Shore AD et al. The effect of gastric banding on kidney stone disease. Urology 2009; 74: 746-749
48. Mole DR, Tomson CR, Mortensen N et al. Renal complications of jejuno-ileal bypass for obesity. Q J Med 2001; 94: 69-77
49. Park AM, Storm DW, Fulmer BR et al. A prospective study of risk factors for nephrolithiasis after Roux-en-Y gastric bypass surgery. J Urol 2009; 182: 2334-2339
50. Penniston KL, Kaplon DM, Gould JC et al. Gastric band placement for obesity is not associated with increased urinary risk of urolithiasis compared to bypass. J Urol 2009; 182: 2340-2346
51. Nelson WK, Houghton SG, Milliner DS et al. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass. Surg Obes Relat Dis 2005; 1: 481-485
52. Sinha MK, Collazo-Clavell ML, Rule A et al. Hyperoxaluric nephro-lithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int 2007; 72: 100-107
53. Asplin JR, Coe FL. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol 2007; 177: 565-569
54. Patel BN, Passman CM, Fernandez A et al. Prevalence of hyperox-aluria after bariatric surgery. J Urol 2009; 181: 161-166
55. Nasr SH, D'Agati VD, Said SM et al. Oxalate nephropathy complicating Roux-en-Y gastric bypass: an underrecognized cause of irreversible renal failure. Clin J Am Soc Nephrol 2008; 3: 1676-1683
56. Wharton R, D'Agati V, Magun AM et al. Acute deterioration of renal function associated with enteric hyperoxaluria. Clin Nephrol 1990; 34: 116-121
57. Harbottle L. Audit of nutritional and dietary outcomes of bariatric surgery patients. Obes Rev 2010